Alexander Pearce

Declining global uranium inventory levels may lend upside support to Cameco Corp.’s (NYSE: CCJ) stock, according to BMO Capital Markets. The Cameco Analyst: Alexander Pearce upgraded the rating for Cameco to Outperform, while raising the price target to C$42 (U.S.$33.63). The Cameco Thesis:...